Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Healthequity (HQY) Net Margin (2016 - 2025)

Historic Net Margin for Healthequity (HQY) over the last 13 years, with Q4 2025 value amounting to 16.05%.

  • Healthequity's Net Margin rose 141500.0% to 16.05% in Q4 2025 from the same period last year, while for Oct 2025 it was 14.86%, marking a year-over-year increase of 64600.0%. This contributed to the annual value of 8.06% for FY2025, which is 24900.0% up from last year.
  • Per Healthequity's latest filing, its Net Margin stood at 16.05% for Q4 2025, which was up 141500.0% from 18.37% recorded in Q3 2025.
  • Over the past 5 years, Healthequity's Net Margin peaked at 18.37% during Q3 2025, and registered a low of 16.14% during Q1 2022.
  • Its 5-year average for Net Margin is 3.64%, with a median of 2.38% in 2024.
  • As far as peak fluctuations go, Healthequity's Net Margin crashed by -190000bps in 2022, and later surged by 160500bps in 2023.
  • Healthequity's Net Margin (Quarter) stood at 2.8% in 2021, then soared by 73bps to 0.76% in 2022, then skyrocketed by 875bps to 5.89% in 2023, then crashed by -68bps to 1.9% in 2024, then soared by 745bps to 16.05% in 2025.
  • Its Net Margin was 16.05% in Q4 2025, compared to 18.37% in Q3 2025 and 16.3% in Q2 2025.